Skip to content
Pass Duke Elder
Textbook / Chapter 7 / Medical retina

Inherited retinal dystrophies

Inherited retinal dystrophies are single-gene diseases in which photoreceptors or the retinal pigment epithelium slowly die. They are individually rare but together are an important cause of sight loss in children and working-age adults, and they are favourite exam material because each has a recognisable pattern of symptoms, fundus signs, electrophysiology and inheritance. This lesson covers retinitis pigmentosa, Stargardt disease, Best disease, cone dystrophy, choroideraemia, Leber congenital amaurosis and RPE65 gene therapy.

9 minute read4 linked questions

Rods, cones and the tests that separate them

The symptoms of a retinal dystrophy follow from which cell fails first. Rods fill the peripheral retina and work in dim light, so rod disease causes night blindness (nyctalopia) and loss of peripheral field with good central acuity. Cones are packed at the macula and give acuity and colour in daylight, so cone or macular disease causes poor acuity, loss of colour vision, a central scotoma and discomfort in bright light (photophobia), with a full peripheral field.

3D atlasRod disease, cone disease and RPE disease give different symptoms and different electrical tests.

Two electrical tests turn this into a diagnosis. The electroretinogram (ERG) records the summed response of the whole retina to a flash. In the dark-adapted (scotopic) eye a dim flash tests rods. In the light-adapted (photopic) eye, a bright flash or a 30 Hz flicker tests cones, because rods cannot follow a flicker that fast. A full-field ERG is abnormal only when photoreceptors are lost across the retina, so it can be normal in disease confined to the macula.

The electro-oculogram (EOG) measures the standing electrical potential across the retinal pigment epithelium (RPE). The potential falls in the dark and rises in the light. The ratio of the light peak to the dark trough is the Arden ratio, and a low ratio means the RPE is not working.

Retinitis pigmentosa

Retinitis pigmentosa (RP) is the commonest inherited retinal dystrophy, affecting roughly 1 in 4,000 people. It is a group of rod-cone dystrophies: rods die first and cones follow. Despite the name, the process is degeneration, not inflammation. More than a hundred genes are known.

The history is of difficulty seeing at night from adolescence or early adult life, followed by bumping into things. Field loss starts as patches in the mid-periphery, about 20 degrees from fixation. The patches join into a ring scotoma, which widens outwards and inwards until only a central tunnel remains. Central acuity is often good until late.

  • Bone spicule pigmentation in the mid-periphery. When photoreceptors die, pigment epithelial cells detach, migrate into the retina and settle around blood vessels.
  • Attenuated arterioles, an early sign.
  • Waxy pallor of the optic disc.

That is the classic triad. Other findings matter because they are treatable causes of extra visual loss: posterior subcapsular cataract, and cystoid macular oedema, which affects up to about a third of patients and may respond to carbonic anhydrase inhibitors such as acetazolamide or dorzolamide. The ERG is reduced early, before the fundus changes, and is eventually unrecordable ('extinguished').

There is no cure for most forms. Management is low-vision support, cataract surgery when needed, treatment of macular oedema and genetic counselling. Trials of high-dose vitamin A were inconclusive.

Inheritance and syndromic forms

RP can be autosomal dominant, autosomal recessive or X-linked, and many patients have no family history. The mode predicts severity. Autosomal dominant disease is the mildest and latest in onset: the rhodopsin gene (RHO) is the classic cause. X-linked disease is the most severe, with poor central vision by middle age in affected men: RPGR is the main gene. Autosomal recessive disease lies between.

About 20 to 30% of RP is syndromic, meaning the pigmentary retinopathy comes with disease elsewhere.

SyndromeInheritanceFeatures besides the retinopathy
Usher syndromeAutosomal recessiveSensorineural deafness. The commonest syndromic form. Type 1: profound deafness from birth with absent vestibular function. Type 2 (about two thirds of cases): moderate to severe hearing loss with normal balance. Type 3: progressive hearing loss
Bardet-Biedl syndromeAutosomal recessiveObesity, polydactyly, renal disease, learning disability
Refsum diseaseAutosomal recessiveRaised phytanic acid, peripheral neuropathy, ataxia. Treated by restricting dietary phytanic acid
Kearns-Sayre syndromeMitochondrialProgressive external ophthalmoplegia, cardiac conduction defects
Syndromes with a pigmentary retinopathy

Macular dystrophies: Stargardt and Best

Stargardt disease is the classic inherited macular dystrophy of childhood and adolescence. It is autosomal recessive and caused by mutations in ABCA4 on chromosome 1. The ABCA4 protein sits in the photoreceptor outer segment and clears a vitamin A by-product of the visual cycle. Without it the by-product is passed to the RPE, where it is converted to a toxic compound (A2E) that makes up much of the pigment lipofuscin. Lipofuscin-loaded RPE cells die and the photoreceptors over them follow.

A child or teenager has reduced central vision in both eyes, often with a fundus that looks nearly normal at first. Later there are yellow-white, fish-tail shaped (pisciform) flecks at the level of the RPE and atrophy of the macula, sometimes in a bull's eye pattern. When flecks are widespread and the macula is relatively spared the picture is called fundus flavimaculatus, a later and milder form of the same disease. On fluorescein angiography the lipofuscin blocks the background glow of the choroid, giving the dark choroid sign in many, but not all, patients. Patients are advised to avoid vitamin A supplements, which add to the load.

Best disease (Best vitelliform macular dystrophy) is autosomal dominant with variable expression, caused by mutations in BEST1 on chromosome 11. The gene encodes bestrophin, an ion channel in the RPE. In childhood a round, yellow, egg-yolk (vitelliform) lesion appears at the macula, and vision is surprisingly good. Over years the yolk settles into a fluid level (pseudohypopyon), breaks up ('scrambled egg') and may end as atrophy or scar. About one in five eyes develops choroidal neovascularisation.

Stargardt diseaseBest disease
InheritanceAutosomal recessiveAutosomal dominant
GeneABCA4BEST1
FundusPisciform flecks, macular atrophyEgg-yolk lesion at the macula
Key testDark choroid on angiography, abnormal autofluorescenceEOG abnormal (Arden ratio 1.5 or less) with a normal ERG
Stargardt disease and Best disease compared

Cone dystrophy and choroideraemia

In a cone dystrophy the cones degenerate first. The symptoms are the mirror image of RP: falling acuity, loss of colour vision, a central scotoma and marked photophobia. The macula may show a bull's eye pattern or look normal. The ERG gives the diagnosis: cone responses, including the 30 Hz flicker, are reduced and delayed, while rod responses are normal at first. Many patients later lose rod function too and are then said to have cone-rod dystrophy, in which night blindness and peripheral field loss come late. ABCA4 is the commonest cause of the recessive form.

Choroideraemia is an X-linked recessive degeneration of the choriocapillaris, RPE and photoreceptors, caused by mutations in the CHM gene, which encodes Rab escort protein 1 (REP-1). Boys have night blindness in the first decade and then lose peripheral field, like RP, but the fundus is different. There is no bone spicule pigment, disc pallor or arteriolar narrowing. Instead, scalloped patches of the mid-periphery lose their RPE and choroid, leaving bare white sclera crossed by large choroidal vessels. The patches spread inwards, and a central island keeps acuity good until about the fifth decade.

Female carriers usually have no symptoms but show patchy pigment mottling in the periphery. The patchiness reflects random X-inactivation (lyonisation). The main differential is gyrate atrophy, an autosomal recessive condition with similar scalloped atrophy and a raised plasma ornithine. Gene therapy for choroideraemia remains investigational.

Leber congenital amaurosis and RPE65 gene therapy

Leber congenital amaurosis (LCA) is the most severe retinal dystrophy: rods and cones are both affected from birth or the first months of life. It is usually autosomal recessive and genetically mixed. CEP290, GUCY2D, CRB1 and RPE65 are among the commoner genes, each accounting for around a tenth of cases. Do not confuse it with Leber hereditary optic neuropathy, a mitochondrial disease of the optic nerve in young adults.

Parents notice that the baby does not fix or follow. There is roving nystagmus, the pupils react sluggishly, and the child may press or poke the eyes (the oculodigital sign). High hyperopia is common. The fundus often looks normal in infancy, so the test that makes the diagnosis is the ERG, which is severely reduced or unrecordable. A normal ERG rules LCA out.

RPE65 is an enzyme in the RPE that belongs to the visual cycle, the pathway that regenerates 11-cis retinal after light has converted it to the all-trans form. Without RPE65 the photoreceptors have no chromophore and cannot respond normally to light, yet many of them survive for some years. That makes the disease suited to gene replacement.

Voretigene neparvovec (Luxturna) is an adeno-associated virus vector carrying a working copy of the RPE65 gene. It is delivered once to each eye by subretinal injection. It was approved in the United States in 2017, the first gene therapy for an eye disease. In England, NICE recommended it in 2019 (highly specialised technology guidance HST11) for people with vision loss from inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations who have sufficient viable retinal cells. NICE judged that trials showed improved vision in the short term, and noted that there is no long-term evidence yet on how long the effect lasts.

Summary

  • Rod disease causes night blindness and peripheral field loss; cone and macular disease cause poor acuity, colour loss, central scotoma and photophobia.
  • Retinitis pigmentosa is a rod-cone dystrophy with the triad of bone spicule pigmentation, attenuated arterioles and waxy disc pallor.
  • In RP the field shows a mid-peripheral ring scotoma, the ERG is reduced then extinguished, and posterior subcapsular cataract and cystoid macular oedema are treatable complications.
  • Autosomal dominant RP is the mildest and X-linked RP the most severe.
  • Usher syndrome is RP with sensorineural deafness and is autosomal recessive; Bardet-Biedl, Refsum and Kearns-Sayre are other syndromic forms.
  • Stargardt disease is autosomal recessive (ABCA4), with pisciform flecks, macular atrophy and a dark choroid on angiography.
  • Best disease is autosomal dominant (BEST1), with an egg-yolk macular lesion and an abnormal EOG despite a normal ERG.
  • Cone dystrophy gives photophobia and colour loss with reduced photopic and 30 Hz flicker ERG responses.
  • Choroideraemia is X-linked (CHM), with scalloped chorioretinal atrophy in boys and patchy pigment change in carrier mothers.
  • Leber congenital amaurosis presents in infancy with nystagmus and an unrecordable ERG; biallelic RPE65 disease can be treated with subretinal voretigene neparvovec (NICE HST11).

Check yourself

Quick recall on this lesson. These are easier than the question bank.

1. What is the usual first symptom of retinitis pigmentosa?
2. Which electrophysiological pattern is characteristic of Best disease?
3. What is the inheritance of Stargardt disease caused by ABCA4?
4. How is voretigene neparvovec given?
Practise 4 questions on this lesson

Written for revision. It is not a source of clinical advice, and guidance changes.